Invoking for the first time a provision “in public interest’’, the drug prices regulator NPPA on Friday revised prices of 21 formulations, allowing a one-time increase of 50% from the existing ceiling price. The NPPA’s move is in response to the pharma industry’s requests over the last two years to allow upward revision in prices.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/34mw2vc
